Previous Article | Next Article ![]()
Journal of Bacteriology, November 2008, p. 7209-7218, Vol. 190, No. 21
0021-9193/08/$08.00+0 doi:10.1128/JB.00481-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Stuart J. McCorrister,
Georgina A. Cardama,
and
Silvia T. Cardona*
Department of Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada
Received 8 April 2008/ Accepted 26 August 2008
Burkholderia cenocepacia is a member of the Burkholderia cepacia complex, a group of metabolically versatile bacteria that have emerged as opportunistic pathogens in cystic fibrosis and immunocompromised patients. Previously a screen of transposon mutants in a rat pulmonary infection model identified an attenuated mutant with an insertion in paaE, a gene related to the phenylacetic acid (PA) catabolic pathway. In this study, we characterized gene clusters involved in the PA degradation pathway of B. cenocepacia K56-2 in relation to its pathogenicity in the Caenorhabditis elegans model of infection. We demonstrated that targeted-insertion mutagenesis of paaA and paaE, which encode part of the putative PA-coenzyme A (CoA) ring hydroxylation system, paaZ, coding for a putative ring opening enzyme, and paaF, encoding part of the putative beta-oxidation system, severely reduces growth on PA as a sole carbon source. paaA and paaE insertional mutants were attenuated for virulence, and expression of paaE in trans restored pathogenicity of the paaE mutant to wild-type levels. Interruption of paaZ and paaF slightly increased virulence. Using gene interference by ingested double-stranded RNA, we showed that the attenuated phenotype of the paaA and paaE mutants is dependent on a functional p38 mitogen-activated protein kinase pathway in C. elegans. Taken together, our results demonstrate that B. cenocepacia possesses a functional PA degradation pathway and that the putative PA-CoA ring hydroxylation system is required for full pathogenicity in C. elegans.
Published ahead of print on 5 September 2008.
Present address: Department of Medical Microbiology and Infectious Diseases, Basic Medical Sciences Building Room 507, University of Manitoba, Winnipeg, Manitoba, Canada R3E 0W3.
Present address: Laboratory of Molecular Oncology, Quilmes National University, Bernal, Argentina.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»